Rubbish
The molecule Petalion is working on is an ADC
Rubbish
Starpharma has been in collaboration with Merck, Genentech, Chase Sun and AstraZeneca for a fair amount of time with potential licensing deals just around corner
Same with in house Phase 2 trials
Isn't it amazing how traders give positive view of company when holding and wanting to sell and paint a negative picture when wanting to buy
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics, page-92
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.002(2.04%) |
Mkt cap ! $41.73M | |||
| Open | High | Low | Value | Volume |
| 9.9¢ | 10.5¢ | 9.9¢ | $49.15K | 486.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 65751 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 226460 | 3 |
View Market Depth
| Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |